Zurich/Berlin, January 2019;
Venture Valuation entered into a partnership with HEALTH MADE IN GERMANY, the export promotion program for the German healthcare industry initiated by the German Federal Ministry for Economic Affairs and Energy. HEALTH MADE IN GERMANY is implemented by Germany Trade & Invest (GTAI), the country’s economic development agency. It is Venture Valuation’s fourth partner in Germany, after BioDeutschland, BioVallley Deutschland, and Cluster Biotechnology North Rhine-Westphalia (BIO NRW).
As per the partnership agreement, Venture Valuation created a directory of life science, MedTech and eHealth companies located in Germany. The directory is now integrated into the HEALTH MADE IN GERMANY’s website and is accessible for free at the address: www.exportinitiative-gesundheitswirtschaft.de/EIG/Navigation/EN/Company-Directory/company-directory.html.
The company directory is part of Biotechgate, a global database developed and owned by Venture Valuation. Biotechgate lists around 52,000 life science companies and other organizations, including 3,500 based in Germany.
‘We are thrilled to partner with organizations like HEALTH MADE IN GERMANY and GTAI. Germany is one of the biggest life science markets in Europe, so the partnership significantly expands our network. We hope the database will enhance the global exposure of German companies’.
Dr. Patrik Frei, Venture Valuation/Biotechgate CEO
‘Germany’s healthcare industry enjoys an excellent reputation worldwide. German medical technology, pharmaceuticals, digital healthcare solutions, and medical biotechnology are in demand around the globe. Our new online directory of more than 3,500 of the country’s healthcare companies is giving interested people everywhere one-click access to possible business partners here”.
Kirsten Herrmann, HEALTH MADE IN GERMANY at Germany Trade and Invest (GTAI)
About the partners:
HEALTH MADE IN GERMANY is the export initiative for the German healthcare industry. It supports international companies and organizations that are interested in establishing contact with potential German partners and suppliers. Set up by the German Federal Ministry for Economic Affairs and Energy (BMWi), the initiative bundles expert market intelligence for easy industry access. The HEALTH MADE IN GERMANY initiative is implemented by Germany Trade & Invest, the economic development agency of the Federal Republic of Germany, on behalf of the BMWi.
Venture Valuation AG – www.venturevaluation.com
Venture Valuation specializes in independent, third-party assessment and valuation of biotechnology, pharma and med-tech companies. Services are provided in the form of independent Valuation Reports to entrepreneurs (seed to pre-IPO) and investors. With offices in Switzerland, Ireland, UK, Canada, USA and Asia, Venture Valuation has an experienced team of scientists and business professionals with expertise in finance, biotechnology, pharmaceutical and regulatory.
Biotechgate – www.biotechgate.com
The Biotechgate Database is a property of Venture Valuation AG, Switzerland. Biotechgate is a global Life Sciences Database containing over 50,000 company profiles and licensing assets and providing the user with information on life science companies, licensing products, financing rounds as well as key data on management structures and technology platforms. It also contains a database of licensing deals and associated financial information on individual deals as well as an investor database.
Would you like to be notified about new reports and other valuable content published by Venture Valuation?